等待開盤 01-30 09:30:00 美东时间
-1.860
-1.59%
今日重点评级关注:HC Wainwright & Co.:维持Soleno Therapeutics"买入"评级,目标价从110美元升至120美元;富国银行:维持Soleno Therapeutics"超配"评级,目标价从106美元升至114美元
01-21 11:42
今日重点评级关注:Benchmark:维持TNL Mediagene"投机性买入"评级,目标价从3.5美元升至14美元;康托·菲茨杰拉德:维持Eupraxia Pharmaceuticals"超配"评级,目标价从11美元升至19美元
01-16 10:04
Barclays analyst Matthew Bouley maintains Builders FirstSource (NYSE:BLDR) with a Overweight and raises the price target from $123 to $136.
01-16 01:25
Wall Street found firm footing to close the week as solid but unspectacular jobs data eased fears of a sharp labor market slowdown while keeping Federal Reserve rate-cut expectations intact.
01-10 02:49
今日重点评级关注:HC Wainwright & Co.:维持MetaVia Inc."买入"评级,目标价从12美元升至40美元;Canaccord Genuity:维持GH Research"买入"评级,目标价从35美元升至39美元
01-07 17:25
UBS analyst John Lovallo maintains Builders FirstSource (NYSE:BLDR) with a Buy and lowers the price target from $166 to $143.
01-07 01:56
今日重点评级关注:富国银行:维持Milestone Pharmaceuticals"超配"评级,目标价从4美元升至8美元;富国银行:维持Kyverna Therapeutics"超配"评级,目标价从31美元升至33美元
2025-12-17 10:46
今日重点评级关注:HC Wainwright & Co.:维持BioCryst Pharma"买入"评级,目标价从30美元升至32美元;TD Cowen:上调Milestone Pharmaceuticals评级至"买入",目标价8美元
2025-12-16 09:36
Jefferies on Monday upgraded Trex (TREX) to Buy from a previous investment rating of Hold. Conversely, the firm downgraded Builders FirstSource (BLDR) to Hold from Buy as part of a broader 2026 outloo...
2025-12-16 03:43
Jefferies analyst Philip Ng downgrades Builders FirstSource (NYSE:BLDR) from Buy to Hold and lowers the price target from $138 to $110.
2025-12-16 00:17